Results 81 to 90 of about 21,131 (181)

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma

Frontiers in Immunology
Chimeric antigen receptor T-cell (CAR-T) therapies have shown promise in glioblastoma clinical studies, but responses remain inconsistent due to heterogeneous tumor antigen expression and immune evasion post-treatment. NKG2D CAR-T cells have demonstrated
Junchen Liu, Junchen Liu, Kun Dai, Kun Dai, Muhammad Auwal Saliu, Muhammad Auwal Saliu, Mansur Dabai Salisu, Mansur Dabai Salisu, Jiangyu Gan, Lukman Olalekan Afolabi, Dehong Yan, Guizhong Zhang, Maoxuan Liu, Maoxuan Liu, Xiaochun Wan, Xiaochun Wan   +15 more
doaj   +1 more source

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes

Biomedicines
NKG2D is an activating receptor expressed by all human NK cells and CD8 T cells. Harnessing the NKG2D/NKG2D ligand axis has emerged as a viable avenue for cancer immunotherapy.
Anthony V. Serritella, Pablo Saenz-Lopez Larrocha, Payal Dhar, Sizhe Liu, Milan M. Medd, Shengxian Jia, Qi Cao, Jennifer D. Wu   +7 more
doaj   +1 more source

NKG2D

AfCS-Nature Molecule Pages, 2009
openaire   +1 more source

Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies-a narrative review. [PDF]

Transl Cancer Res
Zheng Y, Ding W, Chen B, Geng C, Li X.
europepmc   +1 more source

Longitudinal Dynamics of NK-Cell Regulatory Signaling and IVIG Response in Kawasaki Disease. [PDF]

Children (Basel)
Kim Y, Choi I, Choi KS, Jeong IS, Cho HJ.   +4 more
europepmc   +1 more source

Quantitative Analysis of Splenic Natural Killer Cells of Mice Using Imaging Flow Cytometry. [PDF]

Bio Protoc
Amin MN, Mostaq MS, Uddin MB, Liu YY.
europepmc   +1 more source

NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris. [PDF]

Front Immunol
Hooda V, Singh A, Khandpur S, Arava S, Madan T, Sharma A.   +5 more
europepmc   +1 more source

[Research progress of the ULBP-NKG2D axis in autoimmune diseases]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Ma J, Wu J, Jin Y.
europepmc   +1 more source

Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer. [PDF]

J Biol Eng
Lee SG, Lee M, Lee HM, Son GH, Yoon SR, Chae BH, Kim DS, Lee KM, Kim YS.   +8 more
europepmc   +1 more source

cGAS/STING-mediated upregulation of NKG2D ligands in LSCs contributes to enhanced sensitivity to NK cells. [PDF]

Front Oncol
Ouyang Y, Qin Y, Zhang Q, Zhu P, Zhu H.
europepmc   +1 more source